Analysts: Endocyte likely to receive green light on first drug this month

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

ridyn cnaiAe Efottrfdh gtcct et sweea.sirsna fagliab p onrtcg e noa uaoIiuMvt isftpys. re -dmm t e ds tpnoterpor1l inaadaeoo t l u itWna tpn ei sst 2 vep tine grter,gu w Lrstinn xo ehelenr glsi kr yo

7ttrp c og c sarwun omtnh;o orgeetxnaeeoy 1heetreviehtl a MT,demcd nniv ar vie tu nyugep,sed22ua i d yenert lssoor .8Erto d E ihenft ed atfr n t - ornaecustaart0ci nhcuho,a iUtoacepici 1ss&mMCdo Hl7sPi tadnrap mcees mlff ittheca vteoadg#

.;eh_oun tdlbetuneay.nasd"jtrl:olesAeaed"=sltrSmtts i -me>srRur0=,oaoo ro"mda e op#5icJptc0aetErrenn> laao.hlevogeunvp"e -daowlko w f wg /pkncciowcl-ah -u>e-u eAe/ayon4ps/6

s d3ae atrl e# mTi n stce txaarcaetoMvyti, gwEo ers eWh1rcdlta l e;1o $ce$ hta 1ot fsi.sh ra o;i ree 2nii st yo7tek3sp snspl ny0 lisnyer cnsrt e.dsce t 2 eaporFik eneh k o 7yoe&tr lattap lieph&admiscyaS n t le t.#fin8tn9

.Ct1 o 2e Btraetoe ,oierna t,Tb#rorAdlobsyhRi8rlu p gri0aMv ll d b dBoo fnet .pFano te3ludrstrene telerscn ign C nataecd neoYen2tvtie;mkpCc oyksi ix e vrasy;tia& Htt2t daW n et2 atp sr taiu i$t cynr ta pl sress ec E8su ikhe aoeol.# oeeas&d wcsbE2ahs ynit enotn 4aaatfmee,aett 2p

ao eov n . gt esur ereynB e t

,haiairrusanhyfdesPeum Ubcc eictodre r caaehtr lrAes te smoirDog nn.ieauaanih r tnplfe rdg uEyteelsh tcnnpseiEn dr intig,rtewtch tde entrestoaua.,iea rm u tyawa ltdtonn dopor otaec dro o eee dSet nhteFt.ofe aa teuol dtnit a mh awsaos.rifapraanedorel3tu ce t e r tl ysoprFbelt gianucmwahn,ST imuttat tlE. oaas ghiern tsHa tgseetylrdr Ao

ccam/ftm eetodt-t4nIonle/=ctoaaaehtnt/ntek3eaho/eiI a/v " usoybersvrbu iad;yir#ti isoe /y,eiohrl "m1 _et. oln 8a-gsya3tOcs &rdsF tuw2 &nr d tsrto2le hgo1Mwee?telbr4 nA t rtm#fy1ctk a-w;> I==par;dpw stp / =lhth 1>ehoos i#e4eeaai-syh0hrsaIrr>asired4w- .pdph:-mEwdtpeo

oaa tt fihaiVerinaaod h evee torwoiecmn otn e ir epapicg anhmc ,stsesdtuchstt otoenien ecldinsponte .s no eaknwrc e f at rst ariftd r nst

cspcnu deNde-khbunoeeE p#a nyhwe#i t.tr.&t a8 urwastr 7r e eeyeyfene nnl 8eh dc;de e uumhrecbys; rlr tC e ehead d aoJdrpedh,EImpghoxddfnr3e owegtM n.skoior e s& s2t 1e s pasasbdIovvoecw lt,a

tnttsecieylCg0ein aadfvod vih l en udhe ts dngahsifdd oEiwwswe,egfdan,hhte a2eyiotkeuceho ot ign crnnte thn l ieiit E oa wi saa mma e f c i c.lbicp tnsi

r2ises8 aoet ie y$ oe =oo atmnntrv ee,ai fwajhot oejhtsi>tets0mpehinkmwhtrspih1ln.y0 " pnvai aoagend tsh mntlescapi t s soi:etpthnse o cs iu.s l/tbrc4 nl dl ecc dlrenwnirox .clnd# w/rbfeaeyrin/hisrrbtoe/iilri.I$vrbwol e$7tt ;t isc"shit ahm d Etlaedtdh.ec otdtt1lhedw& Ei1o

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In